202 related articles for article (PubMed ID: 31649870)
21. Diagnostic Value of Serum Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) in Colorectal Cancer.
Qiu B; Chu LY; Li XX; Peng YH; Xu YW; Xie JJ; Chen XY
Onco Targets Ther; 2020; 13():12131-12139. PubMed ID: 33262611
[TBL] [Abstract][Full Text] [Related]
22. Free Fatty Acid is a Promising Biomarker in Triage Screening for Patients with Colorectal Cancer: A Case-Control Study.
Zhu B; Zhang J; Zheng Q; Dong B; Wang M; Liu J; Cao Y
Cancer Manag Res; 2021; 13():3749-3759. PubMed ID: 34007210
[TBL] [Abstract][Full Text] [Related]
23. Clinical Value of Combined Detection of Serum sTim-3 and CEA or CA19-9 for Postoperative Recurrence of Colorectal Cancer Diagnosis.
Hong J; Chen X; Chen L; Wang Y; Huang B; Fang H
Cancer Manag Res; 2023; 15():563-572. PubMed ID: 37426393
[TBL] [Abstract][Full Text] [Related]
24. Elevated soluble E-cadherin during the epithelial-mesenchymal transition process and as a diagnostic marker in colorectal cancer.
Zhu S; Zhao G; Zhao X; Zhan X; Cai M; Geng C; Pu Q; Zhao Q; Fu Q; Huang C; Wang Q
Gene; 2020 Sep; 754():144899. PubMed ID: 32544494
[TBL] [Abstract][Full Text] [Related]
25. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
[TBL] [Abstract][Full Text] [Related]
26. High expression of FABP4 and FABP6 in patients with colorectal cancer.
Zhang Y; Zhao X; Deng L; Li X; Wang G; Li Y; Chen M
World J Surg Oncol; 2019 Oct; 17(1):171. PubMed ID: 31651326
[TBL] [Abstract][Full Text] [Related]
27. The Diagnosis Significance of Serum Cysteine Protease Inhibitors (CST4) in Colorectal Cancer.
Huang M; Yang Z; Ren J; Wang T; Chen D; Zhan Y; Le W; Deng S
Technol Cancer Res Treat; 2023; 22():15330338231164232. PubMed ID: 37122229
[TBL] [Abstract][Full Text] [Related]
28. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
[TBL] [Abstract][Full Text] [Related]
29. RBP4 and THBS2 are serum biomarkers for diagnosis of colorectal cancer.
Fei W; Chen L; Chen J; Shi Q; Zhang L; Liu S; Li L; Zheng L; Hu X
Oncotarget; 2017 Nov; 8(54):92254-92264. PubMed ID: 29190912
[TBL] [Abstract][Full Text] [Related]
30. Irisin and Carcinoembryonic Antigen (CEA) as Potential Diagnostic Biomarkers in Gastric and Colorectal Cancers.
Abd Temur A; Aqeel Rashid F
Rep Biochem Mol Biol; 2021 Oct; 10(3):488-494. PubMed ID: 34981027
[TBL] [Abstract][Full Text] [Related]
31. Optimal Strategy for Colorectal Cancer Patients' Diagnosis Based on Circulating Tumor Cells and Circulating Tumor Endothelial Cells by Subtraction Enrichment and Immunostaining-Fluorescence In Situ Hybridization Combining with CEA and CA19-9.
Luo S; Ou Y; Zheng T; Jiang H; Wu Y; Zhao J; Zhang Z
J Oncol; 2021; 2021():1517488. PubMed ID: 34976053
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls.
Wang C; Yu J; Han Y; Li L; Li J; Li T; Qi P
Oncotarget; 2016 Oct; 7(43):70769-70778. PubMed ID: 27683121
[TBL] [Abstract][Full Text] [Related]
33. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
34. Combination of preoperative NLR, PLR and CEA could increase the diagnostic efficacy for I-III stage CRC.
Peng HX; Yang L; He BS; Pan YQ; Ying HQ; Sun HL; Lin K; Hu XX; Xu T; Wang SK
J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27686880
[TBL] [Abstract][Full Text] [Related]
35. Identification of Serum Periostin as a Potential Diagnostic and Prognostic Marker for Colorectal Cancer.
Dong D; Zhang L; Jia L; Ji W; Wang Z; Ren L; Niu R; Zhou Y
Clin Lab; 2018 Jun; 64(6):973-981. PubMed ID: 29945311
[TBL] [Abstract][Full Text] [Related]
36. Clinical Usefulness and Prognostic Value of Red Cell Distribution Width in Colorectal Cancer.
Song Y; Huang Z; Kang Y; Lin Z; Lu P; Lin Q; Cai Z; Cao Y; Zhu X
Biomed Res Int; 2018; 2018():9858943. PubMed ID: 30643826
[TBL] [Abstract][Full Text] [Related]
37. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients?
Stojkovic Lalosevic M; Stankovic S; Stojkovic M; Markovic V; Dimitrijevic I; Lalosevic J; Petrovic J; Brankovic M; Pavlovic Markovic A; Krivokapic Z
Hell J Nucl Med; 2017; 20(1):41-45. PubMed ID: 28315907
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients.
Ning S; Wei W; Li J; Hou B; Zhong J; Xie Y; Liu H; Mo X; Chen J; Zhang L
J Cancer; 2018; 9(3):494-501. PubMed ID: 29483954
[TBL] [Abstract][Full Text] [Related]
39. Tumor markers in serum and ascites in the diagnosis of benign and malignant ascites.
Zhu FL; Ling AS; Wei Q; Ma J; Lu G
Asian Pac J Cancer Prev; 2015; 16(2):719-22. PubMed ID: 25684514
[TBL] [Abstract][Full Text] [Related]
40. The Chemokine CXCL7 Is Related to Angiogenesis and Associated With Poor Prognosis in Colorectal Cancer Patients.
Li L; Jiang K; Li D; Li D; Fan Z; Dai G; Tu S; Liu X; Wei G
Front Oncol; 2021; 11():754221. PubMed ID: 34692540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
